EGFR-TKI resistance promotes immune escape in lung cancer via increased PD-L1 expressionShunli Peng, Wei Wang|Molecular Cancer|2019Cited by 316
Dual PI3K/mTOR Inhibitors, GSK2126458 and PKI-587, Suppress Tumor Progression and Increase Radiosensitivity in Nasopharyngeal CarcinomaTongxin Liu, Wei Wang|Molecular Cancer Therapeutics|2014Cited by 83
Hepatocyte growth factor reduces sensitivity to the epidermal growth factor receptor-tyrosine kinase inhibitor, gefitinib, in lung adenocarcinoma cells harboring wild-type <i>EGFR</i>Hua Yang, Wei Wang|Oncotarget|2016Cited by 12